Skip to main content
Elisa Delbarba on Muck Rack

Elisa Delbarba

As seen in: ASN Journals
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Elisa

Contact Elisa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

|
By Francesco Scolari, Elisa Delbarba, Domenico Santoro, Loreto Gesualdo
| ASN Journals Verified
Clinical Research You have accessRestricted Access Francesco Scolari, Elisa Delbarba, Domenico Santoro, Loreto Gesualdo, Antonello Pani, Nadia Dallera, Laila-Yasmin Mani, Marisa Santostefano, Sandro Feriozzi, Marco Quaglia, Giuliano Boscutti, Angelo Ferrantelli, Carmelita Marcantoni, Patrizia Passerini, Riccardo Magistroni, Federico Alberici, Gian Marco Ghiggeri, Claudio Ponticelli, Pietro Ravani and for the RI-CYCLO Investigators JASN April 2021, 32 (4) 972-982; DOI:...
Open in Who Shared Issue with article?

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

|
By Elisa Delbarba, Domenico Santoro, Loreto Gesualdo, Francesco Scolari
| ASN Journals Verified
Clinical Research You have accessRestricted Access Francesco Scolari, Elisa Delbarba, Domenico Santoro, Loreto Gesualdo, Antonello Pani, Nadia Dallera, Laila-Yasmin Mani, Marisa Santostefano, Sandro Feriozzi, Marco Quaglia, Giuliano Boscutti, Angelo Ferrantelli, Carmelita Marcantoni, Patrizia Passerini, Riccardo Magistroni, Federico Alberici, Gian Marco Ghiggeri, Claudio Ponticelli, Pietro Ravani and for the RI-CYCLO Investigators JASN March 2021, ASN.2020071091; DOI:...
Open in Who Shared Issue with article?

A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.

|
By Federico Alberici, Surgical Specialties, Brescia Italy, Elisa Delbarba
| kidney-international.org
Introduction. SARS-CoV-2 infection is posing challenges to all the health systems in the world. The ideal therapeutic approach is still debated and data on subgroups of patients at high risk still scarce(1). We have developed an internal treatment protocol for the management of renal transplant patients with SARS-CoV-2 pneumonia (2x2Mangement of patients on dialysis and with kidney transplant during COVID-19 coronavirus infection.
Open in Who Shared Issue with article?
See all 3 articles